Cargando…

Green medicine as a harmonizing tool to antivenom therapy for the clinical management of snakebite: The road ahead

Detalles Bibliográficos
Autor principal:	Mukherjee, Ashis K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2012
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3461710/ https://www.ncbi.nlm.nih.gov/pubmed/22885258

Ejemplares similares

Preclinical Evaluation of the Efficacy of Antivenoms for Snakebite Envenoming: State-of-the-Art and Challenges Ahead
por: Gutiérrez, José María, et al.
Publicado: (2017)

Situation of snakebite, antivenom market and access to antivenoms in ASEAN countries
por: Patikorn, Chanthawat, et al.
Publicado: (2022)

Cost of Manufacturing for Recombinant Snakebite Antivenoms
por: Jenkins, Timothy Patrick, et al.
Publicado: (2020)

Antibodies as Snakebite Antivenoms: Past and Future
por: Dias da Silva, Wilmar, et al.
Publicado: (2022)

Effectiveness of repeated antivenom therapy for snakebite-related systemic complications
por: Park, Kyung Hoon, et al.
Publicado: (2019)

Antivenoms for Snakebite Envenoming: What Is in the Research Pipeline?
por: Alirol, Emilie, et al.
Publicado: (2015)

Cost-effectiveness of Antivenoms for Snakebite Envenoming in Nigeria
por: Habib, Abdulrazaq G., et al.
Publicado: (2015)

Recent Advances in Next Generation Snakebite Antivenoms
por: Knudsen, Cecilie, et al.
Publicado: (2018)

Biosynthetic Oligoclonal Antivenom (BOA) for Snakebite and Next-Generation Treatments for Snakebite Victims †
por: Kini, R. Manjunatha, et al.
Publicado: (2018)

Commentary: It's a long road ahead
por: Bernier, Pierre-Luc
Publicado: (2020)

The Need for Next-Generation Antivenom for Snakebite Envenomation in India
por: Vanuopadath, Muralidharan, et al.
Publicado: (2023)

Private medical autopsies - The road ahead!
por: Aggrawal, A
Publicado: (2023)

Effective, polyvalent, affordable antivenom needed to treat snakebite in Nepal
por: Shrestha, Bhola R, et al.
Publicado: (2017)

Snakebite and local envenomation by Boiruna maculata treated without antivenom
por: Terashige, Shou, et al.
Publicado: (2021)

Anti-Metalloprotease P-I Single-Domain Antibodies: Tools for Next-Generation Snakebite Antivenoms
por: Silva, Marcela C. S., et al.
Publicado: (2022)

Snakebite envenoming at MSF: A decade of clinical challenges and antivenom access issues
por: Potet, Julien, et al.
Publicado: (2022)

Cost-Effectiveness of Antivenoms for Snakebite Envenoming in 16 Countries in West Africa
por: Hamza, Muhammad, et al.
Publicado: (2016)

Recent International Progress in Preventive Nephrology and the Road Less Traveled Ahead
por: Vassalotti, Joseph A.
Publicado: (2021)

The road ahead for respiratory therapy
por: West, Andrew
Publicado: (2017)

The Search for Natural and Synthetic Inhibitors That Would Complement Antivenoms as Therapeutics for Snakebite Envenoming
por: Gutiérrez, José María, et al.
Publicado: (2021)

Biogeographic venom variation in Russell’s viper (Daboia russelii) and the preclinical inefficacy of antivenom therapy in snakebite hotspots
por: Senji Laxme, R. R., et al.
Publicado: (2021)

The road ahead
Publicado: (2001)

Current Insights in the Mechanisms of Cobra Venom Cytotoxins and Their Complexes in Inducing Toxicity: Implications in Antivenom Therapy
por: Kalita, Bhargab, et al.
Publicado: (2022)

Radiomics for personalised medicine: the long road ahead
por: Miles, Kenneth
Publicado: (2020)

Recombinant snakebite antivenoms: A cost-competitive solution to a neglected tropical disease?
por: Laustsen, Andreas H., et al.
Publicado: (2017)

Case Report: Treatment of a Severe Puff Adder Snakebite Without Antivenom Administration
por: Wakasugi, Masahiro, et al.
Publicado: (2021)

Plant-Derived Toxin Inhibitors as Potential Candidates to Complement Antivenom Treatment in Snakebite Envenomations
por: Adrião, Asenate A. X., et al.
Publicado: (2022)

Availability, accessibility and use of antivenom for snakebite envenomation in Africa with proposed strategies to overcome the limitations
por: Dalhat, Mahmood Muazu, et al.
Publicado: (2023)

Snakebites and microvesicles: Popping bubbles
por: Bos, Mettine H.A., et al.
Publicado: (2019)

Death Adder Envenoming Causes Neurotoxicity Not Reversed by Antivenom - Australian Snakebite Project (ASP-16)
por: Johnston, Christopher I., et al.
Publicado: (2012)

Potential Utilization of a Polysaccharide from the Marine Algae Gayralia oxysperma, as an Antivenom for Viperidae Snakebites
por: da Silva, Ana Cláudia Rodrigues, et al.
Publicado: (2018)

Acute Severe Anaphylaxis in Nepali Patients with Neurotoxic Snakebite Envenoming Treated with the VINS Polyvalent Antivenom
por: Sharma, Sanjib Kumar, et al.
Publicado: (2019)

A painful journey to antivenom: The therapeutic itinerary of snakebite patients in the Brazilian Amazon (The QUALISnake Study)
por: Cristino, Joseir Saturnino, et al.
Publicado: (2021)

Effect of the time to antivenom administration on recovery from snakebite envenoming-related coagulopathy in French Guiana
por: Houcke, Stéphanie, et al.
Publicado: (2023)

Antivenom access impacts severity of Brazilian snakebite envenoming: A geographic information system analysis
por: Isaacson, Julia Elizabeth, et al.
Publicado: (2023)

Identifying high snakebite risk area under climate change for community education and antivenom distribution
por: Yousefi, Masoud, et al.
Publicado: (2023)

Gene patents and personalized medicine - what lies ahead?
por: Chandrasekharan, Subhashini, et al.
Publicado: (2009)

THE ROLE AND ROAD AHEAD
por: Kumar, K.A.
Publicado: (2001)

Periodontology - The road ahead
por: Thomas, Biju
Publicado: (2014)

JCAS: The Road Ahead
por: Majid, Imran
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_691ks0ausmcq03ffe4gtvfonc5